A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial).

ABSTRACT:

Aims

Professional practice guidelines recommend that pacemaker recipients be followed regularly. However, the majority of scheduled ambulatory visits is unproductive and imposes a heavy burden on the health-care system.

Methods and results

The COMPAS randomized, multicentre, non-inferiority trial examined the safety of long-term remote monitoring of pacemakers. Between December 2005 and January 2008, 538 patients were randomly assigned to remote monitoring follow-up (active group) vs. standard care (control group). The primary objective was to confirm that the proportion of patients who experienced at least one major adverse event (MAE), including all-cause death and hospitalizations for device-related or cardiovascular adverse events, was not >7% higher in the active than i

SUBMITTER: Mabo P 

PROVIDER: S-EPMC3341630 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature